-
Loading metrics
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
- Gloria H. Y. Lin,
- Vien Chai,
- Vivian Lee,
- Karen Dodge,
- Tran Truong,
- Mark Wong,
- Lisa D. Johnson,
- Emma Linderoth,
- Xinli Pang,
- Jeff Winston
x
- Published: October 30, 2017
- https://doi.org/10.1371/journal.pone.0187262